Laura Brege, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 25,000 shares at $30.06 ($752K) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $752k ACAD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PCRX | BUY | 2024-08-19 | $13K | — | Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |